BioRestorative Therapies (BRTXQ) News Today

$1.27
-0.07 (-5.22%)
(As of 04/24/2024 ET)
SourceHeadline
markets.businessinsider.com logoWhy BioRestorative Therapies Is Rising In Pre-market?
markets.businessinsider.com - April 16 at 8:56 AM
msn.com logoBioRestorative Therapies partners with Galen Patient Recruitment
msn.com - April 8 at 10:20 AM
msn.com logoBioRestorative Therapies files to sell 2.51M shares of common stock for holders
msn.com - April 3 at 5:37 PM
forbes.com logo5 Best Affordable Online Therapy Options Of 2024
forbes.com - March 12 at 4:15 PM
msn.com logoBioRestorative Therapies tumbles after private placement
msn.com - February 6 at 2:38 PM
markets.businessinsider.com logoBioRestorative Therapies Presents Preliminary Clinical Data from Phase 2 Study of BRTX-100 in Chronic Lumbar Disc Disease
markets.businessinsider.com - February 5 at 8:58 AM
morningstar.com logoBioRestorative Therapies Inc BRTX
morningstar.com - January 12 at 8:10 PM
money.usnews.com logoOccupational Therapy Assistant Salary
money.usnews.com - December 4 at 5:28 PM
nasdaq.com logoBioRestorative Therapies (FRA:9OF) Price Target Increased by 8.74% to 12.19
nasdaq.com - October 9 at 6:17 PM
benzinga.com logoBioRestorative Therapies And 3 Other Stocks Under $3 Insiders Are Buying
benzinga.com - September 1 at 10:19 AM
benzinga.com logoBioRestorative Therapies (NASDAQ: BRTX) Receives Landmark License From New York State
benzinga.com - July 20 at 8:06 AM
marketwatch.com logoBioRestorative Therapies Shares Lower Premarket on Stock Offering >BRTX
marketwatch.com - July 11 at 9:44 AM
benzinga.com logoEXCLUSIVE: BioRestorative Therapies Tells Benzinga Data Monitoring Committee Allows Co's Chronic Lumbar Disc Disease To Continue Unchanged
benzinga.com - June 27 at 9:56 AM
benzinga.com logoBioRestorative Therapies Announces Key Milestone of Dosing Completion in Safety Cohort of Phase 2 Trial Targeting Chronic Lumbar Disc Disease
benzinga.com - June 12 at 7:19 PM
benzinga.com logoEXCLUSIVE: BioRestorative Completes Dosing In Safety Cohort Of Chronic Lower Back Pain Trial
benzinga.com - June 12 at 7:19 PM
benzinga.com logoEXCLUSIVE: BioRestorative Therapies Wins License from New York State Department of Health To Act As Tissue Bank for Mesenchymal Stem Cell Processing
benzinga.com - May 31 at 8:39 AM
msn.com logoEXCLUSIVE: BioRestorative Therapies' ThermoStem For Metabolic Disorders Expected To Receive Fourth Japanese Patent
msn.com - May 15 at 9:17 AM
marketwatch.com logoBioRestorative Therapies Shares Rise 40% After U.S. Patent Allowance
marketwatch.com - March 3 at 5:10 PM
nbcnews.com logoWhat is red light therapy and does it work?
nbcnews.com - February 26 at 1:42 PM
benzinga.com logo2022 Was A Year Of Growth, Funding, And Positive Results For BioRestorative Therapies
benzinga.com - January 25 at 9:46 AM
benzinga.com logoThe NIH Has Given BioRestorative Therapies A Stamp Of Approval
benzinga.com - November 9 at 8:38 AM
stockhouse.com logoSee What’s Next For The Regenerative Medicine Field -- BioRestorative Intends to Lead The Pack In Stem Cell Therapies!
stockhouse.com - November 2 at 11:24 PM
morningstar.com logoBioRestorative Therapies Inc BRTX Stock Analysis
morningstar.com - September 9 at 4:48 PM
msn.com logoBioRestorative Shares Fall As Enrolment Initiated in Mid-Stage Chronic Back Pain Drug Study
msn.com - June 30 at 5:04 PM
benzinga.com logoBioRestorative Therapies Announces Clinical Site Initiation for the Company's Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)
benzinga.com - June 14 at 3:31 PM
finance.yahoo.com logoBioRestorative Therapies Announces Clinical Site Initiation for the Company’s Phase 2 Clinical Trial to Treat Chronic Lumbar Disc Disease (cLDD)
finance.yahoo.com - June 13 at 7:37 AM
Get BioRestorative Therapies News Delivered to You Automatically

Sign up to receive the latest news and ratings for BRTXQ and its competitors with MarketBeat's FREE daily newsletter.

The Best AI Stock to Own in the World Today is Trading for Just $25 (Ad)

“Titan of Tech” Bets Big on Tiny AI Company He’s made as much as 3,250,000% in just three years on companies like Facebook, Airbnb, and PayPal… But our research shows his latest investment could be his most successful venture yet.

See how you can invest alongside him

BRTXQ Media Mentions By Week

BRTXQ Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

BRTXQ
News Sentiment

0.00

0.41

Average
Medical
News Sentiment

BRTXQ News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

BRTXQ Articles
This Week

0

0

BRTXQ Articles
Average Week

Get BioRestorative Therapies News Delivered to You Automatically

Sign up to receive the latest news and ratings for BRTXQ and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools

This page (OTCMKTS:BRTXQ) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners